Pursuant to Regulation 30 of SEBI( Listing Obligations and Disclosures requirements) Regulations, 2015, Please find attached herewith the Notice convening 31st Annual General Meeting of the Company

39 Omkar Pharvmachem 422. Date: 02" September, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: Submission of Notice of 318 Annual General Meeting of the Members of the Company under regulation 30 of SEBI Listing Obligations and Disclosure requirements) Regulations, 2015 Scrip Code- 532167 Dear Sir/Ma’am, The Notice of 315 Annual General Meeting of the members of the Company scheduled to be held on Wednesday, the 30% day of September, 2026 at Hotel Kanak, Opp-Gujarat College, Ellisbridge, Ahmedabad-380006 Gujarat at 10:30 a.m., containing the business to be transacted thereat, is attached herewith. As per Section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014 and amendments thereto and Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company is providing to its members the facility to cast their Vote by Electronics means on all the Resolution set forth in the notice. The instructions for E-Voting are mentioned in the notes of said notice. You are requested to kindly take the same on record. Thanking You, Yours faithfully, For Omkar Pharmachem Limited Digitally signed by B HAWAN | BHAWANI S GOYAL Date: 2026.09.02 S GOYA 10:28:07 +05'30' Bhawani S Goyal Managing Director DIN: 03255804 Add: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023 Enc- a/a Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Anmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000GJ1995PLC025276, Email: investors.op|@gmail.com, Website: www.omkarpharmachem.co.in 31st ANNUAL REPORT 2025-2026 OMKAR PHARMACHEM LIMITED OMKAR PHARMACHEM LIMITED CIN: L93000GJ1995PLC02527 Email: investors.opl@gmail.com, website: www.omkarpharmachem.co.in, Ph.: 9711811163 Regd. Office: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge, Ahmedabad-380006 Gujarat. NOTICE OF 31 ANNUAL GENERAL MEETING Notice is hereby given that the Thirty First (31st) Annual General Meeting of the Members of the Company is scheduled to be held on Wednesday, the 30th day of September, 2026 at Hotel Kanak, Opp-Gujarat College, Ellisbridge, Ahmedabad-380006 Gujarat at 10:30 a.m. to transact the following business. ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements of the Company i.e. audited Balance Sheet as at 31st March, 2026, Statement of Profit and Loss, Statement of Change in Equity and Cash Flow Statement for the year ended on that date together with the Reports of the Directors and Auditors thereon. 2. To appoint a director in place of Mr. Parminder Sharma (DIN-00176300), who retires by rotation at this Annual General Meeting and being eligible has offered himself for re-appointment. SPECIAL BUSINESS: 3. TO CONSIDER AND APPROVE MATERIAL RELATED PARTY TRANSACTIONS: To consider and if thought fit, to pass, with or without modification(s) the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to Regulation 23(4) and thresholds specified in Schedule XII and such other applicable provisions, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable provisions, if any, of the Companies Act, 2013, as amended, and other applicable laws/ statutory provisions, if any, Company’s Policy on Related Party Transactions and based on the approval/recommendation of the Audit Committee and the Board of directors of the company, approval of the members of the Company be and is hereby accorded to the material related party transactions entered into/ proposed to be entered into (whether individual transaction or transaction(s) taken together or series of transaction(s) or otherwise) as per the details provided in the explanatory statement between company and Chief Financial Officer and Company Secretary of the company (KMPs) a related party of the company on such terms and conditions as may be agreed between the aforesaid parties, aggregating upto Rs. 25,00,000/- (Rupees Twenty Five Lakh Only) during the financial year 2026-27 provided however, that the said transactions shall be carried out at an arm’s length basis and in the ordinary course of business. RESOLVED FURTHER THAT the Board of Directors of the Company and/or Company Secretary of the Company, be and are hereby authorised to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to this resolution.” Date : 31st August, 2026 By Order of the Board Place : Ahmedabad For Omkar Pharmachem Limited Sd/- BHAWANI S GOYAL Managing Director (DIN: 03255804) Address: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023. 31st ANNUAL REPORT 2025-2026 OMKAR PHARMACHEM LIMITED NOTES: 1. A MEMBER ENTITLED TO ATTEND AND VOTE AT THE MEETING IS ENTITLED TO APPOINT A PROXY/ PROXIES TO ATTEND AND VOTE ON A POLL INSTEAD OF HIMSELF/ HERSELF. A PROXY NEED NOT BE A MEMBER OF THE COMPANY. A PERSON CAN ACT AS PROXY ON BEHALF OF MEMBERS NOT EXCEEDING FIFTY (50) AND HOLDING IN THE AGGREGATE NOT MORE THAN TEN PERCENT OF THE TOTAL SHARE CAPITAL OF THE COMPANY. A MEMBER HOLDING MORE THAN TEN PERCENT OF THE TOTAL SHARE CAPITAL OF THE COMPANY CARRYING VOTING RIGHTS MAY APPOINT A SINGLE PERSON AS PROXY AND SUCH PERSON SHALL NOT ACT AS A PROXY FOR ANY OTHER PERSON OR SHAREHOLDER. THE INSTRUMENT APPOINTING THE PROXY SHOULD, HOWEVER, BE DEPOSITED AT THE REGISTERED OFFICE OF THE COMPANY NOT LESS THAN 48 HOURS BEFORE THE COMMENCEMENT OF THE MEETING. PROXIES SHALL NOT HAVE ANY RIGHT TO SPEAK AT THE MEETING. A PROXY FORM IS ANNEXED TO THIS NOTICE. EVERY MEMBER ENTITLED TO VOTE AT THE MEETING, OR ON ANY RESOLUTION TO BE MOVED THEREAT, SHALL BE ENTITLED DURING THE PERIOD BEGINNING 24 HOURS BEFORE THE TIME FIXED FOR THE COMMENCEMENT OF THE MEETING AND ENDING WITH THE CONCLUSION OF THE MEETING, TO IN- SPECT THE PROXIES LODGED, AT ANY TIME DURING THE BUSINESS HOURS OF THE COMPANY, PRO- VIDED THAT NOT LESS THAN THREE DAYS` NOTICE IN WRITING OF THE INTENTION SO TO INSPECT IS GIVEN TO THE COMPANY. 2. The businesses set out in the Notice will be transacted through remote electronic voting system and the Company is providing facility for voting by remote electronic means. Instructions and other information relating to remote e- voting are given in the Notice under Note No. 17. Members attending the meeting, who have not cast their vote by remote e-voting, shall be able to exercise their right to vote at the meeting through ballot papers. Members who have cast their votes by remote e-voting prior to the AGM may attend the AGM but shall not be entitled to cast their votes again. 3. Corporate members intending to send their authorized representatives to attend the Meeting are requested to send to the Company a certified true copy of the Board Resolution authorizing their representative to attend and vote on their behalf at the meeting atleast 3 days before the AGM. 4. Members may please note that SEBI vide its Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 read with SEBI Master Circular No. SEBI/ HO/MIRSD/POD-1/P/CIR/2024/37 dated May 7, 2024 as applicable has mandated the listed companies to issue securities in dematerialized form only while processing service requests viz. Issue of duplicate securities certificate; claim from unclaimed suspense account; renewal/ exchange of securities certificate; endorsement; sub-division/splitting of securities certificate; consolidation of securities certificates/folios; transmission and transposition. Accordingly, Members are requested to make service requests by submitting a duly filled and signed Form ISR – 4, the format of which is available on the Company’s website at https://www.omkarpharmachem.co.in/ under shareholder information tab. It may be noted that any service request can be processed only after the folio is KYC compliant. 5. SEBI vide its SEBI circular no. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2 [Showing first 8,000 characters — download PDF for full document]